We invite members of the BWH neuroscience community to join us for a virtual symposium on Wednesday, September 29th. The symposium, sponsored by the BWH Department of Neurology and the Brigham Research Institute, will feature a keynote address by Dr. Walter J. Koroshetz, Director of National Institute of Neurological Disorders and Stroke at the National Institutes of Health.
As part of Neuroscience Day, we will collect and share short, pre-recorded “lightning talks” from any researchers in the neuroscience community that would like to share their work. Please see below for...
Harvard University, Geological Lecture Hall, 24 Oxford Street, Cambridge, MA
Presented by the Department of Human Evolutionary Biology Colloquium Series
Guest presenter: Dr. Fenna Krienen Postdoctoral Scholar Department of Genetics Harvard Medical School
Abstract: The expansion of the neocortex in primates has led to the emergence of brain regions that have specialized functions and connectivity, are important for cognition, and are compromised in brain disorders. What are the genetic and cellular bases for the reorganization and increased capability...
Harvard Medical School, New Research Building, Room 350, 77 Avenue Louis Pasteur, Boston, MA
Social/Happy Hour to follow!
Extrinsic regulation of hematopoietic stem cell formation Trista North, PhD Associate Professor, HMS and Boston Children's Hospital
Co-receptor feedback shaped the Nodal signaling gradient Adam Carte, G6 Systems, Synthetic, and Quantitative Biology Program Laboratory of Dr. Alexander Schier
Marine Innovations for Cell Culture Presented by: Prof. Andrew Mearns Spragg, Founder & CSO at Jellagen®
During this seminar, you will learn the latest developments in: o Jellyfish collagen, the next generation extracellular matrix o An alternative matrix for cell culture o How jellyfish collagen can improve cell culture performance o Cell culture case study in iPSC derived cell lines o Jellyfish collagen, a biomaterial sharing close homology to human collagen o Company...
The discovery and development of immune checkpoint inhibitors has revolutionized the treatment of certain cancers.Yet, despite these advances, putative biomarker identification, efficacy, and drug resistance still pose significant therapeutic challenges. In this webinar, leaders in immuno-oncology — Elaine Mardis (The Ohio State University) and Jedd Wolchok (Memorial Sloan Kettering Cancer Center) — survey the landscape of research, revealing new approaches for harnessing the potential of this transformative therapeutic.
Brigham and Women's Hospital, Hale Building for Transformative Medicine, 3rd floor Conference Room, 60 Fenwood Road, Boston
BWH Oncology Seminar Series
Guest speaker: Hideho Okada, MD, PhD Director, UCSF Brain Tumor Immunotherapy Center Professor of Neurological Surgery Parker Institute for Cancer Immunotherapy UCSF
Harvard School of Dental Medicine, REB Auditorium, 190 Longwood Avenue, Boston
Science Speaker Series at HSDN
Guest speaker: Yang Chai, DDS, PhD Professor of Craniofacilal Molecular Biology Associate Dean of Research University of Southern California Ostrow School of Dentistry
